DAWN Operating Cash Flow (Statement)
Day One Biopharmaceuticals Inc · Operating Cash Flow (Statement)
DAWN Operating Cash Flow (Statement)
Latest reported-$103.76Mperiod ending
DAWN TTM Cash from Operations (-$13.49M → -$103.76M)
TTM operating cash flow (statement)
High-resolution chart · PNG
DAWN operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -103,757,000 | |
| -119,616,000 | |
| -63,058,000 | |
| -87,381,000 | |
| -78,113,000 | |
| -89,477,000 | |
| -177,294,000 | |
| -170,597,000 | |
| -146,853,000 | |
| -140,791,000 | |
| -126,941,000 | |
| -114,296,000 | |
| -109,874,000 | |
| -87,733,000 | |
| -76,740,000 | |
| -60,359,000 | |
| -48,539,000 | |
| -41,308,000 | |
| -32,665,000 | |
| -21,147,000 | |
| -13,489,000 |